Purpose: To validate a machine learning approach to Virtual intensity-modulated radiation therapy (IMRT) quality assurance (QA) for accurately predicting gamma passing rates using different measurement approaches at different institutions.
| INTRODUCTION
Over 50% of cancer patients receive radiotherapy as partial or full cancer treatment, and radiotherapy is an increasingly complex process. Machine learning is a subfield of data science that focuses on designing algorithms that can learn from and make predictions on data. Machine learning applications in radiotherapy have emerged increasingly in recent years, with applications including predictive modeling of treatment outcome in radiation oncology, [1] [2] [3] [4] [5] [6] [7] treatment optimization, [8] [9] [10] [11] error detection and prevention, [12] [13] [14] [15] and treatment machine quality assurance (QA). [16] [17] [18] [19] These machine learning techniques have provided physicians and physicists information for more effective and accurate treatment delivery as well as the ability to achieve personalized treatment.
To the best of our knowledge, however, little work with machine learning has been explored in the field of dosimetry and QA in clinical radiotherapy. It is common to perform patient-specific pretreatment verification prior to intensity-modulated radiation therapy (IMRT) delivery. This process is time consuming and not altogether instructive due to the myriad of sources that affect a passing result. In an earlier work, a machine learning algorithm, Virtual IMRT QA, was developed that can predict IMRT QA passing rates and identify underlying sources of errors not otherwise apparent. 20 The algorithm identified the correlation between the IMRT plan complexity metrics and gamma passing rates and was validated on a single planning/delivery platform.
The objective of this study is to further validate the approach using a large, heterogeneous dataset using different QA measurement devices (diode-array detectors and portal dosimetry) on different models of treatment machines and at different institutions.
Identifying plans prone to QA failure allows physicists to concentrate resources in developing proactive approaches to QA and provides information on sources of errors needed to strategically improve the workflow of patient care as described in AAPM TG-100. 21 Goals of this study are to provide a framework to establish universal standards and thresholds, intercompare results, safely and efficiently implement adaptive radiotherapy, and in the long term, eliminate failing QA altogether. This represents a fundamental paradigm change in the way in which QA is performed.
| MATERIALS AND METHODS

2.A | Methodologies and data collection
The Virtual IMRT QA framework was previously developed based on 498 IMRT plans, 416 and 82 using 6 and 15 MV, respectively, on 
where D i is the total number of detectors in the analysis and fr x i ð Þ is the mean value of the failing rate of the plan i that depends on its complexity vector x i .
We can model fr according to a Poisson regression as:
where b is a constant vector the same size as x i
Now, given the realization of the data S, let us find the most likely vector b. In order to obtain b, we use Bayes theorem:
where p bjS ð Þ is the posterior probability of b given S, p Sjb ð Þ is the probability of obtaining S given b, p b ð Þ is the prior probability of b, and p S ð Þ is the probability of obtaining S regardless of b. We are interested in finding the b that maximizes the function p bjS ð Þ, which is the same as:
In eq. 4 we have taken into account that p S ð Þ does not depend on b and as such, it can be dropped from the optimization problem.
Assuming all measurements x i ; y i ð Þ are conditionally independent given the model, the probability p Sjb ð Þ can be written as:
And assuming a Laplace distribution with a mean of 0 and variance equal to 2k 2 for p b ð Þ, as customary in Lasso regularization, we
which results in:
As maximizing p bjD ð Þ is equivalent to maximizing log(p bjD ð ÞÞ, eq. 7 can be rewritten as:
Applying the rules of logarithms and dropping the terms that do not depend on b results in:
The workflow of the validation of Virtual IMRT QA model. 
3 | RESULTS
Equation 9
was used to construct histograms of measured versus predicted passing rates using a 3%/3 mm local gamma threshold (Figs. 2 and 3 ). This magnitude commonly called residual is the standard metric to evaluate the performance of regression algorithm in a similar way that Area Under the Curve is used to evaluate performance in classification algorithms. 22 All composite plans measured using diode-array detectors were predicted within 3% accuracy In addition, please note that all predictions are out of sample prediction, that is, the passing rates being predicted are not part of the data used to train the model. patient-specific QA plans and results are required to train the virtual QA model to achieve an accurate prediction. 20 The required training QA data should be readily available assuming a measurement-based clinical patient-specific QA program is in place, and should not impose additional measurement burden on the practicing physicist.
The potential benefit of this approach can be quite significant. For instance, Virtual IMRT QA could be run by the dosimetrist while planning. If an arbitrary threshold of 93.5% for Virtual IMRT QA is set, all plans that satisfy this threshold should pass IMRT QA with a passing rate higher than 90%. These plans could be further measured. However, those that have predicted passing rate smaller than 93.5% could be modified without the need to perform the QA Through workflow improvement and risk analysis, the tool should enhance the overall QA and improve the safety of treatment delivery.
At present, the model is only capable of assessing fixed-beam IMRT planning/delivery; features critical to volumetric-modulated radiotherapy (VMAT) will be incorporated into future machine learning models. This should be acknowledged as a limitation of the current method. Analysis of 3D detectors will require the collection of some of the key delivery information, such as gantry speed, MLC speed, and aperture size, and obtaining these parameters posts potential challenges. With the popularity of this treatment modality, further study in this direction will be a great asset to the community.
In addition, the predictive model was trained to correlate the automatic registration of calculated and measured QA doses which has its pros (uncertainty due to phantom misalignment is removed) and cons (some mechanical errors producing a shift of dose are not detected in QA).
In this study, we have used the formalism as described by Valdes et al. 20 From eq. 9, however, it is clear that contributions from the different metrics were assumed to be linear (multiplication of a constant vector by the vector describing the plan characteristics), that is, no interaction terms between the different characteristics were considered. In addition, at the current stage, different models are needed for different combinations of delivery systems and energies.
Ideally, one would like to incorporate all the data from an institution (delivery device, energy, QA devices, etc.) and input this data into a single mathematical formulation that will predict the gamma passing rate without the need for independent models which increases the data requirement. Even though beam data models for different Linacs/energies are different, they do share important characteristics and from an analytics point of view, it is inefficient to segregate the data by imposing practical constraints. We are currently developing a formulation that will take into account these limitations in order to obtain errors of local gamma passing rates within 2%. This number should be the ultimate goal of any quantitative analysis predicting gamma passing rate because as it has been reported by Nelms et al., some clinical relevant errors could create changes in gamma passing rate in the order of 2%. 25 One possible way to improve accuracy within the current framework would be to separate data by treatment site and build a model for each treatment site. As in the case of different models for different energies, this approach will increase the need for more data. Finally, although we have decided to model here gamma passing rate with 3%/3 mm local analysis (for small targets 3%/2 mm might be more appropriate in the conventional QA), our methodology should not depend on the % dose or distance to agreement selected. That being said, at least in our dataset, stricter metric than 3%/3 mm results in having too much inherent noise for proper modeling.
| CONCLUSIONS
In this work with more extensive QA data, the validity of Virtual IMRT QA to accurately predict gamma passing rates, within 3.5%
error, has been shown for different models of Linacs in different institutions, providing a strong validation of our IMRT QA predictive model. Compared to conventional measurement-based QA, the framework also provides significant insight into both machine and plan characteristics. Software-based, Virtual IMRT QA using machine learning has a unique position in the radiotherapy QA program and further provides a framework for a future integrated risk-based QA program such as that envisioned in AAPM TG-100.
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